GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 Astrocytoma
Phase 2 Suspended
36 enrolled
BRAF
Phase 2 Terminated
5 enrolled 15 charts
Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer
Phase 2 Completed
78 enrolled 11 charts
Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas
Phase 2 Completed
118 enrolled 8 charts
Topotecan and Thalidomide in Treating Patients With Recurrent or Refractory Malignant Glioma
Phase 2 Terminated
5 enrolled
Antineoplaston Therapy in Treating Children With Brain Tumors
Phase 2 Completed
34 enrolled 6 charts
Armodafinil in Treating Fatigue Caused By Radiation Therapy in Patients With Primary Brain Tumors
Phase 2 Completed
54 enrolled 14 charts
Phase II Studies Of Donepezil And Ginkgo Biloba In Irradiated Brain Tumor
Phase 2 Completed
68 enrolled
Thalidomide and Procarbazine in Treating Patients With Recurrent or Progressive Malignant Glioma
Phase 2 Completed
18 enrolled
Valproic Acid, Radiation, and Bevacizumab in Children With High Grade Gliomas or Diffuse Intrinsic Pontine Glioma
Phase 2 Completed
38 enrolled 53 charts
Bevacizumab and Carmustine in Treating Patients With Relapsed or Progressive High-Grade Glioma
Phase 2 Completed
7 enrolled 4 charts
SarCNU in Treating Patients With Recurrent Malignant Glioma
Phase 2 Completed
10 enrolled
Pemetrexed Disodium in Treating Patients With Recurrent Malignant Gliomas, Primary CNS Lymphoma, or Brain Metastases
Phase 2 Unknown
31 enrolled
Bevacizumab in Treating Patients With Recurrent or Progressive Glioma
Phase 2 Completed
55 enrolled 10 charts
Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma Multiforme
Phase 2 Completed
144 enrolled 14 charts
Photodynamic Therapy (PDT) For Recurrent High Grade Gliomas
Phase 2 Terminated
1 enrolled 5 charts
TAVAREC
Phase 2 Completed
155 enrolled
Imetelstat Sodium in Treating Younger Patients With Recurrent or Refractory Brain Tumors
Phase 2 Terminated
43 enrolled 14 charts
Temozolomide and Carmustine in Treating Patients With Anaplastic Glioma
Phase 2 Completed
82 enrolled
Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors
Phase 2 Completed
105 enrolled
Temozolomide in Treating Patients With Recurrent High-Grade Glioma
Phase 2 Completed
60 enrolled 9 charts
Thalidomide, Celecoxib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Malignant Glioma
Phase 2 Completed
Bendamustine Hydrochloride in Treating Patients With Recurrent or Progressive Anaplastic Glioma
Phase 2 Completed
45 enrolled 11 charts
A Randomized Phase II Trial of Vandetanib (ZD6474) in Combination With Carboplatin Versus Carboplatin Alone Followed by Vandetanib Alone in Adults With Recurrent High-Grade Gliomas
Phase 2 Completed
112 enrolled 12 charts
Temozolomide in Treating Patients With Recurrent Glioblastoma Multiforme or Other Malignant Glioma
Phase 2 Completed
47 enrolled 7 charts
Sunitinib in Treating Patients With Recurrent Malignant Gliomas
Phase 2 Completed
31 enrolled 6 charts
Tandutinib Plus Bevacizumab to Treat Recurrent Brain Tumors
Phase 2 Completed
42 enrolled 11 charts
Carboplatin, Temozolomide, and Filgrastim in Treating Patients With Newly Diagnosed or Recurrent High-Grade Glioma
Phase 2 Withdrawn
Carmustine Plus O6-benzylguanine in Treating Patients With Recurrent or Progressive Glioma
Phase 2 Completed
BIBF 1120 for Recurrent High-Grade Gliomas
Phase 2 Completed
37 enrolled 11 charts
Vinorelbine in Treating Children With Recurrent or Refractory Cancers
Phase 2 Completed
50 enrolled
Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) With Bevacizumab and Irinotecan for Malignant Glioma
Phase 2 Completed
20 enrolled
Bevacizumab and Irinotecan in Treating Patients With Recurrent or Refractory Gliomas
Phase 2 Completed
68 enrolled
Magnetic Resonance Imaging and Magnetic Resonance Spectroscopic Imaging in Evaluating Patients Who Are Undergoing Treatment for Gliomas
Phase 2 Completed
250 enrolled
ALA
Phase 2 Unknown
18 enrolled
Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment
Phase 2 Completed
70 enrolled
Radiation Therapy, Temozolomide, Tamoxifen, and Carboplatin in Treating Patients With Malignant Gliomas
Phase 2 Unknown
80 enrolled
Biological Therapy in Treating Patients With Glioblastoma Multiforme
Phase 2 Completed
40 enrolled
Radiation Therapy in Treating Patients With Progressive or Recurrent Malignant Brain Tumors
Phase 2 Completed
Temozolomide in Treating Patients With Recurrent Malignant Glioma
Phase 2 Completed
Irinotecan in Treating Children With Refractory Solid Tumors
Phase 2 Completed
181 enrolled
Ritonavir and Lopinavir in Treating Patients With Progressive or Recurrent High-Grade Glioma
Phase 2 Terminated
19 enrolled 9 charts
Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment
Phase 2 Completed
180 enrolled
Pyrazoloacridine Plus Carboplatin in Treating Patients With Recurrent Glioma
Phase 2 Completed
60 enrolled
Levetiracetam or Pregabalin in Treating Seizures in Patients Undergoing Chemotherapy and/or Radiation Therapy For Primary Brain Tumors
Phase 2 Completed
52 enrolled
Phase (Ph) II Bevacizumab + Erlotinib for Patients (Pts) With Recurrent Malignant Glioma (MG)
Phase 2 Completed
57 enrolled 16 charts
Chemotherapy and Vaccine Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Recurrent or Refractory Brain Cancer
Phase 2 Completed
Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or Oligodendroglioma
Phase 2 Completed
60 enrolled
Zoledronate in Preventing Osteoporosis in Patients With Primary Malignant Glioma
Phase 2 Completed
60 enrolled 10 charts
Docetaxel in Treating Children With Recurrent Solid Tumors
Phase 2 Completed
20 enrolled